-
-
-
-
-
-
-
IMUNON reports improved cancer drug trial results, posts narrower loss
-
-
-
-
-
-
-
Celsion Corporation (IMNN) Misses Q2 EPS by 183c
-
-
-
-
-
-
-
Celsion Corporation (IMNN) Tops Q3 EPS by 5c
-
-
-
-
-
-
-
IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
-
-
-
-
-
-
-
IMUNON to Hold Fourth Quarter 2022 Financial Results and Business Update Conference Call on Thursday, March 30, 2023
-
-
-
-
-
1,222,631 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

